Currently out of the existing stock ratings of Daniel Brims, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Daniel Brims

Work Performance Price Targets & Ratings Chart

Analyst Daniel Brims, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 66.67% that have a potential upside of 11.8% achieved within 40 days. Previously, Daniel Brims worked at HCWAINWRIGHT.

Daniel Brims’s has documented 17 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on TTPH, Tetraphase Pharmaceuticals at 09-Sep-2015.

Wall Street Analyst Daniel Brims

Analyst best performing recommendations are on TTPH (TETRAPHASE PHARMACEUTICALS).
The best stock recommendation documented was for TTPH (TETRAPHASE PHARMACEUTICALS) at 9/9/2015. The price target of $220 was fulfilled within 9 days with a profit of $30.2 (15.91%) receiving and performance score of 17.68.

Average potential price target upside

TTPH Tetraphase Pharmaceuticals CMRX Chimerix MEIP MEI Pharma

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

4 years 6 months 14 days ago
(07-May-2020)

1/2 (50%)

$36.05 (72.09%)

304

Buy

$140

5 years 2 months 18 days ago
(03-Sep-2019)

0/4 (0%)

$69.6 (98.86%)

Buy

$380

5 years 6 months 11 days ago
(10-May-2019)

0/3 (0%)

$224.8 (144.85%)

Buy

6 years 2 months 1 days ago
(20-Sep-2018)

0/3 (0%)

$150.4 (116.05%)

Buy

$140

$137.8 (6263.64%)

$120

6 years 2 months 24 days ago
(28-Aug-2018)

0/3 (0%)

$81.4 (104.62%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Daniel Brims?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?